Anavaj Sakuntabhai

Title: Anavaj Sakuntabhai: Innovator in Immunogenic Compositions

Introduction

Anavaj Sakuntabhai is a notable inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the development of innovative solutions for viral infections. With a total of three patents to his name, his work is recognized for its potential impact on public health.

Latest Patents

Sakuntabhai's latest patents focus on a Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition. This invention provides means, including polynucleotides, vectors, and cells that express the chimeric polyepitope. The patent also relates to a composition or vaccine that includes at least one of the polyepitope, polynucleotide, vector, or host cell for use in preventing Zika virus infections in human subjects, as well as for preventing both Zika and dengue virus infections.

Career Highlights

Throughout his career, Anavaj Sakuntabhai has worked with prestigious institutions such as Institut Pasteur and Universidad El Bosque. His research has contributed to advancements in vaccine development and immunology, showcasing his commitment to addressing global health challenges.

Collaborations

Sakuntabhai has collaborated with esteemed colleagues, including Claude Roth and Etienne Simon-Loriere. These partnerships have enhanced the scope and impact of his research, fostering innovation in the field.

Conclusion

Anavaj Sakuntabhai's work exemplifies the importance of innovation in combating viral diseases. His contributions to immunogenic compositions are paving the way for future advancements in vaccine development.